Clinical Trial Update: Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient [Phase 2]

View source ↗

Summary

Phase 2 real-world study evaluating platinum-containing dual-drug chemotherapy followed by large-fractionated radiotherapy in combination with tislelizumab for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-containing dual drug chemotherapy (platinum-containing dual drug chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Zibo Municipal Hospital | Conditions: NSCLC, Tislelizumab | Phase 2 | Status: RECRUITING